From Nasdaq.: 2024-08-01 10:22:52

Validea’s guru fundamental report for Pfizer Inc (PFE) shows that it rates highest using the Value Investor model based on Benjamin Graham’s strategy. With a 71% rating, the stock is considered a large-cap growth stock in the Biotechnology & Drugs industry. The Value Investor model screens for stocks with low P/B and P/E ratios, low debt, and solid long-term earnings growth. While PFE passes most of the criteria for this model, it fails the current ratio and long-term debt to net current assets ratio tests. Overall, the strategy has some interest in the stock, but not strong interest based on the score of 71%.



Read more at Nasdaq.: Guru Fundamental Report for PFE – Benjamin Graham